ROYAL BANK OF CANADA

Bank

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1000275 TORONTO, A6

Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$29,030,375

+$1,974,866 QoQ

Shares Held

963,824

+11.2% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 97% Shared 2% None 1%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Sep 30, 2022

CallValue

$1,979,571

CallShares

245,300

PutValue

$1,319,445

PutShares

163,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $672,203,105 across 64 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,974,284	$233,380,104
2	RDY	Dr Reddys Laboratories Ltd	9,984,082	$138,279,533
3	BHC	Bausch Health Companies Inc.	11,363,498	$61,362,887
4	NBIX	Neurocrine Biosciences Inc	332,300	$43,777,199
5	VTRS	Viatris Inc	2,907,645	$39,282,278
6	UTHR	UNITED THERAPEUTICS Corp	59,152	$35,075,949
7	HLN	Haleon plc	3,063,916	$30,669,795
8	TEVA	Teva Pharmaceutical Industries Ltd This page	963,824	$29,030,375

All Filings in TEVA

Export CSV

32 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$29,030,375	963,824	+11.2%	Shares	Defined	2026-05-15
2025-12-31	$27,055,509	866,886	-3.3%	Shares	Defined	2026-02-17
2025-09-30	$18,115,295	896,797	-48.7%	Shares	Defined	2025-11-14
2025-06-30	$29,282,246	1,747,151	+47.8%	Shares	Defined	2025-11-21
2025-03-31	$18,166,783	1,181,964	+0.4%	Shares	Defined	2025-11-21
2024-12-31	$25,954,368	1,177,603	+17.2%	Shares	Defined	2025-02-14
2024-09-30	$18,102,042	1,004,553	+95.1%	Shares	Defined	2024-11-14
2024-06-30	$8,365,465	514,798	+30.0%	Shares	Defined	2024-11-06
2024-03-31	$5,588,715	396,082	+23.0%	Shares	Defined	2024-11-05
2023-12-31	$3,362,628	322,091	-0.7%	Shares	Defined	2024-02-14
2023-09-30	$3,308,787	324,391	-1.6%	Shares	Defined	2023-11-14
2023-06-30	$2,482,419	329,671	+23.4%	Shares	Defined	2023-08-14
2023-03-31	$2,364,265	267,149	+3.9%	Shares	Defined	2023-05-15
2022-12-31	$2,343,945	257,012	+57.2%	Shares	Defined	2023-02-14
2022-09-30	$1,319,445	163,500	-33.3%	Put	Sole	2022-11-14
2022-09-30	$1,979,571	245,300	-46.6%	Call	Sole	2022-11-14
2022-09-30	$3,710,075	459,737	-14.7%	Shares	Defined	2022-11-14
2022-06-30	$4,054,784	539,200	+36.1%	Call	Sole	2022-08-15
2022-06-30	$2,979,249	396,177	-58.1%	Shares	Defined	2022-08-15
2022-03-31	$8,868,110	944,421	-14.4%	Shares	Defined	2022-05-16
2021-12-31	$8,836,347	1,103,165	+238.1%	Shares	Defined	2022-02-14
2021-12-31	$2,613,663	326,300	-66.7%	Put	Sole	2022-02-14
2021-09-30	$9,542,021	979,674	+33.1%	Shares	Defined	2021-11-15
2021-06-30	$7,284,931	735,852	+1.8%	Shares	Defined	2021-08-16
2021-03-31	$8,341,916	722,870	-22.7%	Shares	Defined	2021-07-20
2020-12-31	$9,021,453	934,866	+109.3%	Shares	Defined	2021-02-16
2020-12-31	$4,310,655	446,700	+329.5%	Put	Defined	2021-02-16
2020-12-31	$1,003,600	104,000	-77.0%	Call	Defined	2021-02-16
2020-09-30	$4,074,950	452,270	-8.2%	Shares	Defined	2020-11-16
2020-06-30	$6,072,731	492,517	+987.2%	Shares	Defined	2020-08-14
2020-03-31	$406,794	45,300	-90.4%	Call	Defined	2020-06-16
2020-03-31	$4,239,400	472,094	—	Shares	Defined	2020-06-16
No filing history on record for this holder in this stock.